Functional Antibodies against VAR2CSA in Nonpregnant Populations from Colombia Exposed to Plasmodium falciparum and Plasmodium vivax

ABSTRACT In pregnancy, parity-dependent immunity is observed in response to placental infection with Plasmodium falciparum. Antibodies recognize the surface antigen, VAR2CSA, expressed on infected red blood cells and inhibit cytoadherence to the placental tissue. In most settings of malaria endemicity, antibodies against VAR2CSA are predominantly observed in multigravid women and infrequently in men, children, and nulligravid women. However, in Colombia, we detected antibodies against multiple constructs of VAR2CSA among men and children with acute P. falciparum and Plasmodium vivax infection. The majority of men and children (>60%) had high levels of IgGs against three recombinant domains of VAR2CSA: DBL5ε, DBL3X, and ID1-ID2. Surprisingly, these antibodies were observed only in pregnant women, men, and children exposed either to P. falciparum or to P. vivax. Moreover, the anti-VAR2CSA antibodies are of high avidity and efficiently inhibit adherence of infected red blood cells to chondroitin sulfate A in vitro, suggesting that they are specific and functional. These unexpected results suggest that there may be genotypic or phenotypic differences in the parasites of this region or in the host response to either P. falciparum or P. vivax infection outside pregnancy. These findings may hold significant clinical relevance to the pathophysiology and outcome of malaria infections in this region.

[1]  E. Arango,et al.  Molecular detection of malaria at delivery reveals a high frequency of submicroscopic infections and associated placental damage in pregnant women from northwest Colombia. , 2013, American Journal of Tropical Medicine and Hygiene.

[2]  S. Luckhart,et al.  Abundance, behavior and entomological inoculation rates of anthropophilic anophelines from a primary Colombian malaria endemic area , 2013, Parasites & Vectors.

[3]  P. Bigey,et al.  First-trimester Plasmodium falciparum infections display a typical "placental" phenotype. , 2012, The Journal of infectious diseases.

[4]  T. Theander,et al.  Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria* , 2012, The Journal of Biological Chemistry.

[5]  A. Oleinikov,et al.  A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children , 2012, PloS one.

[6]  F. Ayala,et al.  Multiple independent introductions of Plasmodium falciparum in South America , 2011, Proceedings of the National Academy of Sciences.

[7]  D. Scherman,et al.  The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. , 2011, The Journal of infectious diseases.

[8]  P. C. Narváez,et al.  Epidemiology and control of malaria in Colombia. , 2011, Memorias do Instituto Oswaldo Cruz.

[9]  R. Pleass,et al.  Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1 , 2011, Proceedings of the National Academy of Sciences.

[10]  N. D. Djadid,et al.  Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission. , 2011, American Journal of Tropical Medicine and Hygiene.

[11]  J. Carmona-Fonseca,et al.  Diagnosis of gestational, congenital, and placental malaria in Colombia: comparison of the efficacy of microscopy, nested polymerase chain reaction, and histopathology. , 2011, The American journal of tropical medicine and hygiene.

[12]  T. Theander,et al.  High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. , 2011, Vaccine.

[13]  A. Cowman,et al.  Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  O. Lund,et al.  Insight into Antigenic Diversity of VAR2CSA-DBL5ε Domain from Multiple Plasmodium falciparum Placental Isolates , 2010, PloS one.

[15]  O. Lund,et al.  Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal , 2010, Malaria Journal.

[16]  T. Theander,et al.  Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies , 2010, Journal of molecular biology.

[17]  T. Theander,et al.  Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites. , 2009, International journal for parasitology.

[18]  M. Ndao,et al.  Multiplexed Real-Time PCR Assay for Discrimination of Plasmodium Species with Improved Sensitivity for Mixed Infections , 2009, Journal of Clinical Microbiology.

[19]  Ole Lund,et al.  Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA , 2008, PLoS pathogens.

[20]  B. Gamain,et al.  Disruption of Var2csa Gene Impairs Placental Malaria Associated Adhesion Phenotype , 2007, PloS one.

[21]  Y. Ogata,et al.  The distinct proteome of placental malaria parasites. , 2007, Molecular and biochemical parasitology.

[22]  K. Marsh,et al.  Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. , 2007, The American journal of tropical medicine and hygiene.

[23]  A. Oleinikov,et al.  Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. , 2007, The Journal of infectious diseases.

[24]  F. T. Ter Kuile,et al.  Epidemiology and burden of malaria in pregnancy. , 2007, The Lancet. Infectious diseases.

[25]  B. Gamain,et al.  Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. , 2006, Microbes and infection.

[26]  Ole Lund,et al.  Epitope Mapping and Topographic Analysis of VAR2CSA DBL3X Involved in P. falciparum Placental Sequestration , 2006, PLoS pathogens.

[27]  M. Wahlgren,et al.  Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin , 2006, Proceedings of the National Academy of Sciences.

[28]  L. Hviid,et al.  Plasmodium falciparum Parasites Expressing Pregnancy-Specific Variant Surface Antigens Adhere Strongly to the Choriocarcinoma Cell Line BeWo , 2006, Infection and Immunity.

[29]  T. Theander,et al.  Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. , 2006, Journal of Infectious Diseases.

[30]  T. Theander,et al.  High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. , 2005, The Journal of infectious diseases.

[31]  M. Wahlgren,et al.  SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes , 2005, The Journal of experimental medicine.

[32]  B. Gamain,et al.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. , 2005, The Journal of infectious diseases.

[33]  P. Deloron,et al.  Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. , 2004, The Journal of infectious diseases.

[34]  Thor G. Theander,et al.  Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria , 2004, The Journal of experimental medicine.

[35]  L. Hviid The immuno‐epidemiology of pregnancy‐associated Plasmodium falciparum malaria: a variant surface antigen‐specific perspective , 2004, Parasite immunology.

[36]  F. Nosten,et al.  Malaria in pregnancy and the endemicity spectrum: what can we learn? , 2004, Trends in parasitology.

[37]  Thomas Lavstsen,et al.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.

[38]  P. Preiser,et al.  Small Variant STEVOR Antigen Is Uniquely Located within Maurer's Clefts in Plasmodium falciparum-Infected Red Blood Cells , 2002, Eukaryotic Cell.

[39]  B. Gamain,et al.  Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. , 2000, Molecular and biochemical parasitology.

[40]  Q. Cheng,et al.  stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. , 1998, Molecular and biochemical parasitology.

[41]  S. Looareesuwan,et al.  Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: evidence for chondroitin sulfate a as a cytoadherence receptor. , 1996, The American journal of tropical medicine and hygiene.

[42]  Patrick E. Duffy,et al.  Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta , 1996, Science.

[43]  O. Doumbo,et al.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.

[44]  J. Vuust,et al.  Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli , 1995, Clinical and diagnostic laboratory immunology.

[45]  M. Akogbeto,et al.  Malaria transmission in the lagoon area of Cotonou, Benin. , 1992, Parassitologia.

[46]  J. Barnwell,et al.  Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes , 1984, The Journal of experimental medicine.

[47]  M. Fried,et al.  Analysis of CSA-binding parasites and antiadhesion antibodies. , 2002, Methods in molecular medicine.